Pharmacovigilance “is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems” (World Health Organization-2002). It arises from the need to evaluate the safety and effectiveness of medications available on the market to prevent unnecessary harm to patients. Pharmacovigilance is a shared responsibility involving different stakeholders: the health authority (COFEPRIS), pharmaceutical industry, distributors, pharmacies, and fundamentally, healthcare professionals and patients.

Sanfer is committed to the well-being of patients, which is why it has a Corporate Pharmacovigilance Unit with the philosophy of ‘Ensuring the health of patients and consumers by offering safe and effective medications through a solid and effective Pharmacovigilance system, guaranteeing a benefit through absolute adherence to national and international standards and guidelines, making decisions always based on knowledge, analysis, and risk management, but above all with professional ethics and commitment to the population.